STTK
Shattuck Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.79
−2.44%5
Insider buys (3m)
4
Insider sells (3m)
-$129.1K
Net value (3m)
+48.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | Sale | 410 | $7.01 |
| Jul 7, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 12,153 | $3.57 |
| Jul 7, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 410 | $3.57 |
| Jul 2, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | Sale | 23,365 | $7.08 |
| Jul 2, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 23,365 | $3.57 |
| Jul 2, 2026 | Pandite Arundathy N. · officer: Chief Medical Officer | Sale | 30,000 | $7.01 |
| Jul 2, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | Sale | 100 | $7.07 |
| Jul 2, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 100 | $3.57 |
| Jun 15, 2026 | ORBIMED ADVISORS LLC · director | Purchase | 208,333 | $0.00 |
| Jun 15, 2026 | ORBIMED ADVISORS LLC · director | Purchase | 1,041,667 | $0.00 |
| Jun 15, 2026 | Ashiya Mona · director | Purchase | 208,333 | $0.00 |
| Jun 15, 2026 | Ashiya Mona · director | Purchase | 1,041,667 | $0.00 |
| Jun 11, 2026 | SIEGALL CLAY B · director | Purchase | 62,500 | $4.00 |
| Jun 2, 2026 | Boudreau Helen M · director | A-Award | 81,000 | $5.95 |
| Jun 2, 2026 | SIEGALL CLAY B · director | A-Award | 81,000 | $5.95 |
| Jun 2, 2026 | Ashiya Mona · director | A-Award | 81,000 | $5.95 |
| Jun 2, 2026 | Gibson Neil W · director | A-Award | 81,000 | $5.95 |
| Jun 2, 2026 | Golumbeski George · director | A-Award | 81,000 | $5.95 |
| Jun 2, 2026 | Baker Daniel G. · director | A-Award | 81,000 | $5.95 |
| May 27, 2026 | SIEGALL CLAY B · director | A-Award | 128,054 | $1.08 |
| May 27, 2026 | SIEGALL CLAY B · director | M-Exempt | 128,054 | $1.08 |
| May 21, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 5,122 | $1.08 |
| May 21, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | A-Award | 5,122 | $1.08 |
| May 18, 2026 | Stout Stephen · officer: See Remarks | M-Exempt | 12,805 | $1.08 |
| May 18, 2026 | Stout Stephen · officer: See Remarks | A-Award | 12,805 | $1.08 |
| May 14, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | Sale | 2,032 | $7.01 |
| May 14, 2026 | Pandite Arundathy N. · officer: Chief Medical Officer | Sale | 30,000 | $6.61 |
| May 14, 2026 | Neill Andrew R · officer: Chief Financial Officer | A-Award | 64,027 | $1.08 |
| May 14, 2026 | Neill Andrew R · officer: Chief Financial Officer | M-Exempt | 64,027 | $1.08 |
| May 14, 2026 | Shukla Abhinav A. · officer: Chief Technical Officer | M-Exempt | 2,032 | $3.57 |
Institutional positioning
13F filings over the trailing two quarters
New 24Increased 33Reduced 16Sold out 82
| Filer | Action | Shares | Filed |
|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 9,865,558 | May 15, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 6,306,127 | May 15, 2026 |
| REDMILE GROUP, LLC | Unchanged | 5,539,724 | May 15, 2026 |
| PROSIGHT MANAGEMENT, LP | Increased | 5,004,439 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 4,644,957 | May 15, 2026 |
| NEXTBio Capital Management LP | Unchanged | 3,149,907 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,277,176 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 1,782,788 | May 15, 2026 |
| CLARK ESTATES INC/NY | Unchanged | 1,475,648 | May 11, 2026 |
| PINNACLE ASSOCIATES LTD | Increased | 1,368,223 | Apr 22, 2026 |
| ABRDN PLC | Increased | 1,159,321 | Apr 29, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 1,031,049 | May 15, 2026 |
| AMERIPRISE FINANCIAL INC | Increased | 905,707 | Jul 17, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Reduced | 800,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 763,745 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 7, 2026